# US Neuromarketing Technology Market

> US Neuromarketing Technology Market Size, Share and Trends Analysis Report by Technology (FMRI, EEG, Eye tracking, PET, and MEG) by Solutions (Customer experience, People Engagement, Project Management, and Product Development) and by End User - Forecast till 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 5.16%
- **2024:** $ 5.75 Billion
- **2025:** $ 6.05 Billion
- **2035:** $ 10 Billion
- **Key Players:** Neurosense (DE), Nielsen (US), Emotiv (AU), iMotions (DK), BrainCo (US), NeuroFocus (US), Mindlab International (GB), SensoMotoric Instruments (DE), Cortexica (GB)

**Report ID:** MRFR/ICT/13388-HCR · **Pages:** 100 · **Author:** Nirmit Biswas & Garvit Vyas · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/us-neuromarketing-technology-market-14915

---

## Market Summary

## United States Neuromarketing Technology Market Overview

The

[US neuromarketing technology market](../../../reports/neuromarketing-technology-market-5340)

is experiencing significant growth as businesses increasingly recognize the potential of leveraging neuroscience to understand consumer behavior and preferences. This emerging field combines traditional marketing techniques with cutting-edge neuroscience to gain deeper insights into consumer decision-making processes. Neuromarketing technologies such as EEG (electroencephalography), fMRI (functional magnetic resonance imaging), and eye-tracking systems are being utilized to measure and analyze consumers' cognitive and emotional responses to marketing stimuli. These insights enable companies to tailor their marketing strategies and campaigns more effectively, resulting in improved customer engagement and higher conversion rates. 

In recent years, the demand for neuromarketing technologies in the US has been steadily rising across various industries, including retail, advertising, entertainment, and consumer goods. Businesses are investing in these technologies to gain a competitive edge by understanding the subconscious factors that influence consumer purchasing decisions. By tapping into consumers' emotions and subconscious reactions, companies can create more impactful and persuasive marketing messages, product designs, and customer experiences. This heightened understanding of consumer behavior allows businesses to refine their branding, packaging, and advertising efforts to better resonate with their target audiences.

The application of neuromarketing technology extends beyond traditional advertising and product development. Market research firms and consumer insights agencies are utilizing these tools to conduct in-depth studies on consumer preferences, perceptions, and engagement with various products and services. 

The data collected from neuroscientific studies provides invaluable information for businesses seeking to optimize their marketing strategies and enhance the overall customer experience. Additionally, neuromarketing technologies are increasingly being integrated into e-commerce platforms to track and analyze consumer interactions, leading to more personalized and relevant online shopping experiences. Furthermore, the US neuromarketing technology market is witnessing a surge in investment and innovation, with startups and established companies developing advanced neuroimaging devices, software, and analytical tools. These advancements are driving the market forward, making neuromarketing technologies more accessible and affordable for businesses of all sizes. 

As a result, the adoption of neuromarketing approaches is becoming more widespread, with companies recognizing the value of data-driven insights derived from neuroscience principles. Despite the promising growth and potential of the US neuromarketing technology market, ethical considerations and privacy concerns surrounding the collection and application of neural data remain important focal points. As the industry continues to evolve, regulatory frameworks and guidelines are being developed to ensure the responsible and ethical use of neuromarketing technologies. Additionally, transparency and consent regarding the collection and utilization of neural data are integral to maintaining consumer trust and safeguarding privacy rights.

## Market Drivers

### Rise of Digital Marketing Channels

The neuromarketing technology market is benefiting from the rise of digital marketing channels. As more consumers engage with brands online, understanding their behavior in digital environments becomes essential. Neuromarketing technologies can analyze how users interact with digital content, providing insights that help optimize online marketing strategies. The digital advertising market in the US is projected to surpass $200 billion by 2025, creating a fertile ground for neuromarketing applications. This trend suggests that as digital marketing continues to evolve, the neuromarketing technology market will likely expand in tandem, offering innovative solutions for brands.

### Increased Focus on Consumer Experience

The neuromarketing technology market is significantly influenced by the increased focus on consumer experience. Companies are recognizing that understanding the emotional and psychological factors that drive consumer decisions is crucial for success. Neuromarketing technologies provide insights into how consumers perceive brands and products, allowing businesses to enhance their customer experience strategies. This shift is evident in the growing number of companies investing in neuromarketing research, with expenditures in this area expected to exceed $500 million by 2025. As organizations prioritize consumer experience, the neuromarketing technology market is poised for substantial growth.

### Emerging Trends in Consumer Neuroscience

The neuromarketing technology market is being shaped by emerging trends in consumer neuroscience. Research in this field is uncovering new insights into how consumers make decisions, driven by factors such as emotions, memory, and social influences. These findings are prompting marketers to adopt more scientifically grounded approaches to their strategies. The increasing collaboration between neuroscientists and marketers is fostering innovation in the neuromarketing technology market, with new tools and methodologies being developed. As consumer neuroscience continues to evolve, it is expected to play a pivotal role in shaping marketing practices, potentially leading to a market growth rate of 15% annually.

### Advancements in Brain Imaging Technologies

The neuromarketing technology market is experiencing a surge due to advancements in brain imaging technologies. Techniques such as functional magnetic resonance imaging (fMRI) and electroencephalography (EEG) are becoming increasingly sophisticated, allowing marketers to gain deeper insights into consumer behavior. These technologies enable the measurement of brain activity in response to marketing stimuli, providing valuable data that can inform advertising strategies. The market for fMRI systems alone is projected to reach approximately $1.5 billion by 2026, indicating a robust growth trajectory. As these imaging technologies become more accessible and affordable, their integration into marketing strategies is likely to expand, enhancing the effectiveness of campaigns in the neuromarketing technology market.

### Growing Demand for Personalized Marketing Solutions

The neuromarketing technology market is driven by the growing demand for personalized marketing solutions. Consumers increasingly expect brands to tailor their offerings to individual preferences, and neuromarketing technologies facilitate this by analyzing emotional and cognitive responses. By leveraging data from neuromarketing studies, companies can create targeted campaigns that resonate with specific demographics. This trend is reflected in the increasing investment in neuromarketing tools, with the market expected to grow at a CAGR of around 20% over the next five years. As businesses recognize the value of personalized marketing, the neuromarketing technology market is likely to see continued expansion.

## Future Outlook

The [Neuromarketing Technology Market](https://www.marketresearchfuture.com/reports/neuromarketing-technology-market-5340) is projected to grow at a 5.16% CAGR from 2025 to 2035, driven by advancements in neuroscience and data analytics.

**New opportunities:**

- Development of AI-driven consumer behavior prediction tools.
- Integration of biometric feedback systems in retail environments.
- Expansion of neuromarketing consultancy services for SMEs.

By 2035, the neuromarketing technology market is expected to be robust and innovative.

## Segment Insights

### By Application: Neuroscience Research (Largest) vs. Neuroprosthetics (Fastest-Growing)

In the US neuromarketing technology market, Neuroscience Research holds a significant share of the application segment, serving as the backbone for various innovative studies and analyses in consumer behavior. Clinical Diagnostics and Neurological Therapy also contribute to the market's diversity, allowing for improved understanding and treatment of neurological conditions, while Therapeutic Devices capture notable attention for their practical applications in healthcare. Neuroprosthetics is rapidly gaining momentum as technological advancements enhance its feasibility and effectiveness, appealing to both research and therapeutic applications.

Growth trends indicate a strong upward trajectory in the application segment, spurred by continuous advancements in brain imaging and neurofeedback technologies. Increased funding in neuroscience research, along with heightened awareness of mental health issues, drives demand for Clinical Diagnostics and Therapeutic Devices. Meanwhile, the rise of Neuroprosthetics is fueled by an aging population and an increasing number of neurological disorders, ensuring that this segment will remain a focal point of innovation and market interest.

Therapeutic Devices (Dominant) vs. Neuroprosthetics (Emerging)

Therapeutic Devices represent a dominant force in the US neuromarketing technology market, providing innovative solutions for a variety of psychological and neurological disorders. These devices, such as transcranial magnetic stimulation systems and neurofeedback devices, are essential for enhancing therapeutic outcomes and patient engagement. Neuroprosthetics, as an emerging segment, utilizes cutting-edge technology to restore lost functions due to neural impairment. This includes devices that interface directly with the nervous system for applications in mobility and sensory restoration. The rapid evolution of neuroprosthetics is driven by technological innovations and an increasing focus on personalized medicine, making it a highly promising area for future developments and investments.

### By Product Type: Neuroimaging Devices (Largest) vs. Neuromodulation Devices (Fastest-Growing)

In the US neuromarketing technology market, Neuroimaging Devices currently hold the largest market share, driven by their extensive use in cognitive research and understanding consumer behavior. Meanwhile, Neuromodulation Devices are rapidly gaining traction as they are increasingly being recognized for their potential to influence consumer responses and optimize marketing strategies.

The growth of these segments is fueled by continuous innovations in technology and increasing adoption by various sectors, including healthcare, retail, and advertising. As businesses seek more precise insights into consumer preferences and decision-making processes, the demand for both Neuroimaging and Neuromodulation Devices is expected to surge, paving the way for novel applications in neuromarketing strategies.

Neuroimaging Devices (Dominant) vs. Neuromodulation Devices (Emerging)

Neuroimaging Devices are characterized by their ability to provide detailed insights into brain activity and cognitive processes, making them an essential tool in the US neuromarketing technology market. These devices include fMRI, EEG, and PET scanners, which are widely adopted for their reliability and accuracy. In contrast, Neuromodulation Devices, such as transcranial magnetic stimulation (TMS) and deep brain stimulation (DBS), are emerging as innovative technologies that seek to manipulate brain activity. While Neuroimaging Devices dominate the market, Neuromodulation Devices are quickly gaining interest due to their potential to influence consumer behavior directly, driving growth and exploration into new neuromarketing applications.

### By End Use: Hospitals (Largest) vs. Research Centers (Fastest-Growing)

In the US neuromarketing technology market, hospitals hold the largest market share as they increasingly integrate advanced technologies into patient care, enhancing both diagnostics and treatment strategies. Research centers follow closely, leveraging neuromarketing tools for innovative studies that drive the market forward. Academic institutions and home care are growing segments but currently contribute less to the overall market share.

The growth trends in this segment are driven by the increasing assimilation of technological advancements in healthcare. Hospitals are investing heavily in neuromarketing technologies to improve patient experiences and outcomes. Research centers are distinguished by their innovative use of these technologies, making them the fastest-growing area. In addition, the rise of personalized medicine is prompting academic institutions to adopt neuromarketing research methodologies, while home care is benefiting from user-friendly neuromarketing tools that empower caregivers.

Hospitals (Dominant) vs. Research Centers (Emerging)

Hospitals are the dominant players in the US neuromarketing technology market, utilizing these technologies to enhance patient engagement and clinical outcomes through advanced behavioral analysis. Their focus is on improving operational efficiency and patient satisfaction, leading to increased investments in neuromarketing tools. In contrast, research centers are emerging as influential contributors, utilizing neuromarketing technologies for groundbreaking studies. They focus on understanding consumer behavior and cognitive responses, which in turn shapes marketing strategies across various sectors. While hospitals capitalize on neuromarketing for immediate clinical benefits, research centers are pioneering long-term studies that could redefine market approaches.

### By Technology: Functional Magnetic Resonance Imaging (Largest) vs. Electroencephalography (Fastest-Growing)

In the US neuromarketing technology market, Functional Magnetic Resonance Imaging (fMRI) maintains a dominant position due to its ability to provide high-resolution images of brain activity. It commands a substantial share of the market, attracting the interest of marketers looking to understand consumer behavior on a deeper level. In contrast, Electroencephalography (EEG) has been gaining traction, owing to its cost-effectiveness and ease of use, appealing to both academic researchers and commercial practitioners alike. 

Growth trends indicate a robust expansion in the sector, with fMRI remaining essential for detailed research while EEG technology rapidly evolves. Driving factors include increased demand for real-time data, the rise of digital marketing, and advancements in neurotechnology, making these tools invaluable for understanding that informs marketing strategies, enhancing consumer engagement and targeting efficacy.

Technology: fMRI (Dominant) vs. EEG (Emerging)

Functional Magnetic Resonance Imaging (fMRI) stands as the cornerstone of the US neuromarketing technology market, providing precise mapping of brain activity in response to various stimuli. Its ability to capture neural responses with high spatial resolution makes it a preferred choice among researchers and brand strategists looking to delve into the intricacies of consumer decision-making. Meanwhile, Electroencephalography (EEG) represents an emerging powerhouse, prized for its rapid data acquisition and cost-effectiveness. As it gains acceptance in commercial applications, EEG is becoming a valuable tool for understanding consumer reactions in real-time, offering insights that complement the more detailed but slower fMRI data. Together, these technologies are reshaping how brands approach marketing strategies.

## Competitive Benchmarking

The neuromarketing technology market is currently characterized by a dynamic competitive landscape, driven by advancements in neuroscience and technology integration. Key players such as Nielsen (US), BrainCo (US), and iMotions (DK) are at the forefront, each adopting distinct strategies to enhance their market positioning. Nielsen (US) focuses on leveraging its extensive data analytics capabilities to provide insights that drive consumer engagement, while BrainCo (US) emphasizes innovation in brain-computer interface technology, aiming to create more intuitive user experiences. iMotions (DK) has positioned itself as a leader in biometric research, integrating various data sources to offer comprehensive consumer insights. Collectively, these strategies contribute to a competitive environment that is increasingly reliant on technological advancements and data-driven decision-making.In terms of business tactics, companies are increasingly localizing manufacturing and optimizing supply chains to enhance operational efficiency. The market structure appears moderately fragmented, with several players vying for market share, yet the influence of major companies remains substantial. This competitive structure fosters an environment where innovation and strategic partnerships are essential for growth and sustainability.

In October  Nielsen (US) announced a partnership with a leading AI firm to enhance its neuromarketing analytics platform. This collaboration is expected to integrate advanced machine learning algorithms, allowing for more precise consumer behavior predictions. The strategic importance of this move lies in Nielsen's ability to offer clients deeper insights into consumer preferences, thereby solidifying its market leadership.

In September  BrainCo (US) launched a new line of wearable devices designed to measure cognitive responses in real-time. This product introduction is significant as it not only expands BrainCo's product portfolio but also positions the company to capture a growing segment of the market focused on real-time data analytics. The ability to provide immediate feedback on consumer reactions could enhance marketing strategies across various sectors.

In August  iMotions (DK) secured a major contract with a global retail chain to implement its biometric research tools in over 500 stores. This strategic move underscores iMotions' commitment to expanding its footprint in the retail sector, where understanding consumer behavior is critical. The contract is likely to enhance the company's visibility and credibility in the market, further driving its growth.

As of November  current trends in the neuromarketing technology market include a pronounced shift towards digitalization, sustainability, and the integration of AI technologies. Strategic alliances are increasingly shaping the competitive landscape, enabling companies to pool resources and expertise. Looking ahead, it is anticipated that competitive differentiation will evolve, with a greater emphasis on innovation and technology rather than price-based competition. Companies that can reliably integrate advanced technologies into their offerings are likely to gain a competitive edge, reflecting a broader industry trend towards enhanced supply chain reliability and consumer-centric solutions.

## Report Scope

| MARKET SIZE 2024 | 5.75(USD Billion) |
| --- | --- |
| MARKET SIZE 2025 | 6.05(USD Billion) |
| MARKET SIZE 2035 | 10.0(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.16% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | Neurosense (DE), Nielsen (US), Emotiv (AU), iMotions (DK), BrainCo (US), NeuroFocus (US), Mindlab International (GB), SensoMotoric Instruments (DE), Cortexica (GB) |
| Segments Covered | Application, Product Type, End Use, Technology |
| Key Market Opportunities | Integration of artificial intelligence in neuromarketing technology enhances consumer insights and engagement strategies. |
| Key Market Dynamics | Growing consumer behavior insights drive innovation and competition in the neuromarketing technology market. |
| Countries Covered | US |

## Frequently Asked Questions

**Q: What was the market valuation of the US neuromarketing technology market in 2024?**
A: The market valuation was $5.75 Billion in 2024.

**Q: What is the projected market valuation for the US neuromarketing technology market by 2035?**
A: The projected valuation for 2035 is $10.0 Billion.

**Q: What is the expected CAGR for the US neuromarketing technology market during the forecast period 2025 - 2035?**
A: The expected CAGR during this period is 5.16%.

**Q: Which segments are included in the US neuromarketing technology market?**
A: Key segments include Neuroscience Research, Clinical Diagnostics, Therapeutic Devices, Neurological Therapy, and Neuroprosthetics.

**Q: What are the projected valuations for the Neuroscience Research segment by 2035?**
A: The projected valuation for the Neuroscience Research segment is expected to reach $2.5 Billion by 2035.

**Q: Which companies are considered key players in the US neuromarketing technology market?**
A: Key players include Neurosense, Nielsen, Emotiv, iMotions, BrainCo, NeuroFocus, Mindlab International, SensoMotoric Instruments, and Cortexica.

**Q: What is the projected valuation for the Neuroimaging Devices segment by 2035?**
A: The Neuroimaging Devices segment is projected to reach $2.5 Billion by 2035.

**Q: What is the expected growth for the Clinical Diagnostics segment by 2035?**
A: The Clinical Diagnostics segment is expected to grow to $2.0 Billion by 2035.

**Q: What are the projected valuations for the end-use segment of Research Centers by 2035?**
A: The Research Centers end-use segment is projected to reach $3.0 Billion by 2035.

**Q: What is the expected valuation for the Deep Brain Stimulation technology segment by 2035?**
A: The Deep Brain Stimulation technology segment is expected to reach $1.5 Billion by 2035.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-neuromarketing-technology-market-14915*